Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/8111
Full metadata record
DC FieldValueLanguage
dc.contributor.authorManikutty, S.-
dc.contributor.authorPathiparambil, Bino-
dc.date.accessioned2010-08-28T05:58:28Z-
dc.date.available2010-08-28T05:58:28Z-
dc.date.copyright2004-
dc.date.issued2010-08-28T05:58:28Z-
dc.identifier.urihttp://hdl.handle.net/11718/8111-
dc.description.abstractA case which involves a decision on whether to go ahead and in what way regarding a potential cure for cancel developed by a startup firm. Involves scenario projection and if the instructor so desires, Real Options Analysis.en
dc.language.isoenen
dc.subjectHealthcareen
dc.subjectImmune Systemen
dc.titleNat-Immune and the CoU-1 Projecten
dc.typeCases and Notesen
Appears in Collections:Cases and Notes

Files in This Item:
There are no files associated with this item.


Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.